Dosage & Administration Biomarker testing Drug label People also ask

Adcetris

(brentuximab vedotin)

brentuximab vedotin 50 MG Injection [Adcetris]

Dosage & administration

* Administer only as an intravenous infusion over 30 minutes .
* The recommended dose as monotherapy is 1.8 mg/kg up to a maximum of 180 mg every 3 weeks .
* The recommended dose in combination with chemotherapy for previously untreated Stage III or IV cHL is 1.2 mg/kg up to a maximum of 120 mg every 2 weeks for a maximum of 12 doses .
* The recommended dose in combination with chemotherapy for previously untreated PTCL is 1.8 mg/kg up to a maximum of 180 mg every 3 weeks for 6 to 8 doses .
* Reduce dose in patients with mild hepatic impairment .

biomarker testing

Adcetris clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Adcetris prescribing information

Contact Medical Science Liaison Report Adverse Event

Adcetris FAQs

How is the dosage of Adcetris?Adcetris is available in 1 dosages, including 50 mg Injection

What does Adcetris treat?Adcetris treats Hodgkin Disease and Immunoblastic Large-Cell Lymphoma

What is Adcetris made of?Adcetris contains brentuximab vedotin which is a CD30-directed Immunoconjugate

How Is Adcetris Administered?Adcetris is administered as a Injectable

What Are The Adcetris Mechanism Of Action?Adcetris mechanism of action is CD30-directed Antibody Interactions

FAQ Data Source